Cargando…

A review of tazarotene in the treatment of photodamaged skin

Chronic sun exposure leads to photodamage, which is characterized clinically by fine and coarse wrinkles, dyspigmentation, telangiectasia, laxity, roughness and a sallow appearance. Many treatments claim to reduce the signs of photodamage, however evidence from randomized controlled trials (RCT) to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogden, Stephanie, Samuel, Miny, Griffiths, Christopher EM
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2544371/
https://www.ncbi.nlm.nih.gov/pubmed/18488880
_version_ 1782159180199624704
author Ogden, Stephanie
Samuel, Miny
Griffiths, Christopher EM
author_facet Ogden, Stephanie
Samuel, Miny
Griffiths, Christopher EM
author_sort Ogden, Stephanie
collection PubMed
description Chronic sun exposure leads to photodamage, which is characterized clinically by fine and coarse wrinkles, dyspigmentation, telangiectasia, laxity, roughness and a sallow appearance. Many treatments claim to reduce the signs of photodamage, however evidence from randomized controlled trials (RCT) to support these claims is limited. The use of topical retinoids, particularly tretinoin, isotretinoin and tazarotene, has been shown to significantly reduce signs of photodamage both clinically and histologically. Over recent years a number of RCTs, have affirmed that topical tazarotene is an effective and safe treatment for photodamaged skin.
format Text
id pubmed-2544371
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-25443712009-05-20 A review of tazarotene in the treatment of photodamaged skin Ogden, Stephanie Samuel, Miny Griffiths, Christopher EM Clin Interv Aging Review Chronic sun exposure leads to photodamage, which is characterized clinically by fine and coarse wrinkles, dyspigmentation, telangiectasia, laxity, roughness and a sallow appearance. Many treatments claim to reduce the signs of photodamage, however evidence from randomized controlled trials (RCT) to support these claims is limited. The use of topical retinoids, particularly tretinoin, isotretinoin and tazarotene, has been shown to significantly reduce signs of photodamage both clinically and histologically. Over recent years a number of RCTs, have affirmed that topical tazarotene is an effective and safe treatment for photodamaged skin. Dove Medical Press 2008-03 2008-03 /pmc/articles/PMC2544371/ /pubmed/18488880 Text en © 2008 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Ogden, Stephanie
Samuel, Miny
Griffiths, Christopher EM
A review of tazarotene in the treatment of photodamaged skin
title A review of tazarotene in the treatment of photodamaged skin
title_full A review of tazarotene in the treatment of photodamaged skin
title_fullStr A review of tazarotene in the treatment of photodamaged skin
title_full_unstemmed A review of tazarotene in the treatment of photodamaged skin
title_short A review of tazarotene in the treatment of photodamaged skin
title_sort review of tazarotene in the treatment of photodamaged skin
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2544371/
https://www.ncbi.nlm.nih.gov/pubmed/18488880
work_keys_str_mv AT ogdenstephanie areviewoftazaroteneinthetreatmentofphotodamagedskin
AT samuelminy areviewoftazaroteneinthetreatmentofphotodamagedskin
AT griffithschristopherem areviewoftazaroteneinthetreatmentofphotodamagedskin
AT ogdenstephanie reviewoftazaroteneinthetreatmentofphotodamagedskin
AT samuelminy reviewoftazaroteneinthetreatmentofphotodamagedskin
AT griffithschristopherem reviewoftazaroteneinthetreatmentofphotodamagedskin